Skip to main content
Top
Published in: Infectious Agents and Cancer 1/2024

Open Access 01-12-2024 | Cervical Cancer | Research

The global burden of cervical cancer requiring surgery: database estimates

Authors: Emma R Allanson, Syed Nabeel Zafar, Chidinma P Anakwenze, Kathleen M Schmeler, Edward L Trimble, Surbhi Grover

Published in: Infectious Agents and Cancer | Issue 1/2024

Login to get access

Abstract

Background

Scaling up surgical services for cervical cancer in low and middle income countries requires quantification of the need for those services. The aim of this study was to estimate the global burden of cervical cancer for which access to surgery is required.

Methods

This was a retrospective analysis of publicly available data. Cervical cancer incidence was extracted for each country from the World Health Organization, International Agency for Research, Global Cancer Observatory. The proportion of cases requiring surgery was extrapolated from the United States Surveillance, Epidemiology and End-Result database. The need for cervical cancer surgery was tested against development indicators.

Results

Data were available for 175 countries, representing 2.9 billion females aged 15 and over. There were approximately 566,911 women diagnosed with cervical cancer (95% CI 565,462–568,360). An estimated 56.9% of these women (322,686) would require surgery for diagnosis, treatment or palliation (95% CI 321,955 − 323,417). Cervical cancers for which surgery is required represent less than 1% of cancers in high income countries, and nearly 10% of cancers in low income countries.

Conclusions

At least 300,000 cervical cancer cases worldwide require access to surgical services annually. Gathering data on available cervical cancer surgery services in LMIC are a critical next step.
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424.
3.
go back to reference Kingham TP, Alatise OI, Vanderpuye V, Casper C, Abantanga FA, Kamara TB, et al. Treatment of cancer in sub-saharan Africa. Lancet Oncol. 2013;14(4):e158–e67.CrossRefPubMed Kingham TP, Alatise OI, Vanderpuye V, Casper C, Abantanga FA, Kamara TB, et al. Treatment of cancer in sub-saharan Africa. Lancet Oncol. 2013;14(4):e158–e67.CrossRefPubMed
4.
go back to reference Meara JG, Leather AJ, Hagander L, Alkire BC, Alonso N, Ameh EA, et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. The Lancet. 2015;386(9993):569–624.CrossRef Meara JG, Leather AJ, Hagander L, Alkire BC, Alonso N, Ameh EA, et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. The Lancet. 2015;386(9993):569–624.CrossRef
5.
go back to reference World Health Organization. Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. Geneva; 2020. World Health Organization. Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. Geneva; 2020.
7.
go back to reference Kokka F, Bryant A, Brockbank E, Powell M, Oram D. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced Cervical cancer. Cochrane Database of Systematic Reviews. 2015(4). Kokka F, Bryant A, Brockbank E, Powell M, Oram D. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced Cervical cancer. Cochrane Database of Systematic Reviews. 2015(4).
8.
go back to reference Zafar SN, Siddiqui AH, Channa R, Ahmed S, Javed AA, Bafford A. Estimating the global demand and delivery of Cancer Surgery. World J Surg. 2019;43(9):2203–10.CrossRefPubMed Zafar SN, Siddiqui AH, Channa R, Ahmed S, Javed AA, Bafford A. Estimating the global demand and delivery of Cancer Surgery. World J Surg. 2019;43(9):2203–10.CrossRefPubMed
13.
go back to reference Ologunde R, Maruthappu M, Shanmugarajah K, Shalhoub J. Surgical care in low and middle-income countries: burden and barriers. Int J Surg. 2014;12(8):858–63.CrossRefPubMed Ologunde R, Maruthappu M, Shanmugarajah K, Shalhoub J. Surgical care in low and middle-income countries: burden and barriers. Int J Surg. 2014;12(8):858–63.CrossRefPubMed
14.
go back to reference Holmer H, Lantz A, Kunjumen T, Finlayson S, Hoyler M, Siyam A, et al. Global distribution of surgeons, anaesthesiologists, and obstetricians. The Lancet Global Health. 2015;3:9–S11.CrossRef Holmer H, Lantz A, Kunjumen T, Finlayson S, Hoyler M, Siyam A, et al. Global distribution of surgeons, anaesthesiologists, and obstetricians. The Lancet Global Health. 2015;3:9–S11.CrossRef
15.
16.
go back to reference Johnston C, Ng JS, Manchanda R, Tsunoda AT, Chuang L. Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): common efforts and challenges. Gynecologic Oncol Rep. 2017;20:9–14.CrossRef Johnston C, Ng JS, Manchanda R, Tsunoda AT, Chuang L. Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): common efforts and challenges. Gynecologic Oncol Rep. 2017;20:9–14.CrossRef
17.
go back to reference Lopez MS, Baker ES, Milbourne AM, Gowen RM, Rodriguez AM, Lorenzoni C, et al. Project ECHO: a Telementoring Program for Cervical Cancer Prevention and Treatment in Low-Resource settings. J Glob Oncol. 2016;3(5):658–65.CrossRefPubMedPubMedCentral Lopez MS, Baker ES, Milbourne AM, Gowen RM, Rodriguez AM, Lorenzoni C, et al. Project ECHO: a Telementoring Program for Cervical Cancer Prevention and Treatment in Low-Resource settings. J Glob Oncol. 2016;3(5):658–65.CrossRefPubMedPubMedCentral
18.
go back to reference International Gynecologic Cancer Society. IGCS Gynecologic Oncology Global Curriculum and Mentorship Program. 2019. International Gynecologic Cancer Society. IGCS Gynecologic Oncology Global Curriculum and Mentorship Program. 2019.
19.
go back to reference Benard VB, Watson M, Saraiya M, Harewood R, Townsend JS, Stroup AM, et al. Cervical cancer survival in the United States by race and stage (2001–2009): findings from the CONCORD-2 study. Cancer. 2017;123(Suppl 24):5119–37.CrossRefPubMed Benard VB, Watson M, Saraiya M, Harewood R, Townsend JS, Stroup AM, et al. Cervical cancer survival in the United States by race and stage (2001–2009): findings from the CONCORD-2 study. Cancer. 2017;123(Suppl 24):5119–37.CrossRefPubMed
20.
go back to reference Allanson ER, Powell A, Bulsara M, Lee HL, Denny L, Leung Y, et al. Morbidity after surgical management of Cervical cancer in low and middle income countries: a systematic review and meta-analysis. PLoS ONE. 2019;14(7):e0217775.CrossRefPubMedPubMedCentral Allanson ER, Powell A, Bulsara M, Lee HL, Denny L, Leung Y, et al. Morbidity after surgical management of Cervical cancer in low and middle income countries: a systematic review and meta-analysis. PLoS ONE. 2019;14(7):e0217775.CrossRefPubMedPubMedCentral
21.
go back to reference Sengayi-Muchengeti M, Joko‐Fru WY, Miranda‐Filho A, Egue M, Akele‐Akpo MT, N’da G et al. Cervical cancer survival in sub‐Saharan Africa by age, stage at diagnosis and Human Development Index (HDI): a population‐based registry study. Int J Cancer. 2020. Sengayi-Muchengeti M, Joko‐Fru WY, Miranda‐Filho A, Egue M, Akele‐Akpo MT, N’da G et al. Cervical cancer survival in sub‐Saharan Africa by age, stage at diagnosis and Human Development Index (HDI): a population‐based registry study. Int J Cancer. 2020.
22.
go back to reference Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, et al. Mortality impact of achieving WHO Cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet (London England). 2020;395(10224):591–603.CrossRefPubMed Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, et al. Mortality impact of achieving WHO Cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet (London England). 2020;395(10224):591–603.CrossRefPubMed
Metadata
Title
The global burden of cervical cancer requiring surgery: database estimates
Authors
Emma R Allanson
Syed Nabeel Zafar
Chidinma P Anakwenze
Kathleen M Schmeler
Edward L Trimble
Surbhi Grover
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Infectious Agents and Cancer / Issue 1/2024
Electronic ISSN: 1750-9378
DOI
https://doi.org/10.1186/s13027-023-00562-3

Other articles of this Issue 1/2024

Infectious Agents and Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine